Bausch Health Enters Material Definitive Agreement
Ticker: BHC · Form: 8-K · Filed: May 21, 2025 · CIK: 885590
Sentiment: neutral
Topics: material-definitive-agreement, company-history
TL;DR
Bausch Health just signed a big deal, filing an 8-K for a material definitive agreement.
AI Summary
On May 20, 2025, Bausch Health Companies Inc. entered into a material definitive agreement. The filing also includes financial statements and exhibits related to this agreement. The company was formerly known as Valeant Pharmaceuticals International, Inc. and has undergone previous name changes from BIOVAIL Corp and BIOVAIL CORP INTERNATIONAL.
Why It Matters
This filing indicates a significant new contract or partnership for Bausch Health, which could impact its future revenue and strategic direction.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new financial obligations or strategic shifts that carry inherent business risks.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- Valeant Pharmaceuticals International, Inc. (company) — Former company name
- BIOVAIL Corp (company) — Former company name
- BIOVAIL CORP INTERNATIONAL (company) — Former company name
- May 20, 2025 (date) — Date of earliest event reported
FAQ
What is the nature of the material definitive agreement entered into by Bausch Health Companies Inc. on May 20, 2025?
The filing does not specify the details of the material definitive agreement, only that one was entered into.
What are the previous names of Bausch Health Companies Inc. mentioned in the filing?
The filing states that Bausch Health Companies Inc. was formerly known as Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, and BIOVAIL CORP INTERNATIONAL.
What is the SEC file number for Bausch Health Companies Inc.?
The SEC file number for Bausch Health Companies Inc. is 001-14956.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 20, 2025.
What is the primary SIC code listed for Bausch Health Companies Inc.?
The primary SIC code listed for Bausch Health Companies Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Bausch Health Companies Inc. (BHC).